Clinical Trial Update: A Study of LY4175408 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating LY4175408 in participants with advanced cancers, including non-small cell lung cancer, small cell lung cancer, endometrial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• LY4175408

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma | Phase 1 | Status: RECRUITING